A NOVEL INTRONIC SPLICE SITE TAFAZZIN GENE
MUTATION DETECTED PRENATALLY IN A FAMILY
WITH BARTH SYNDROME
Bakšienė M, Benušienė E, Morkūnienė A, Ambrozaitytė L, Utkus A, Kučinskas V
*Corresponding Author: Marija Bakšienė, M.D., Department of Human and Medical Genetics, Vilnius University,
Santarişkių Str. 2, LT-08861 Vilnius, Lithuania. Tel: +3702365116. E-mail: m.baksiene@gmail. com
page: 95
|
|
REFERENCES
1. Barth PG, Scholte HR, Berden JM, van der Klei-Van
Moorsel JM, Luyt Houwen IE, van’t Veer Korthof
ET, et al. An X-linked mitochondrial disease affecting
cardiac muscle, skeletal muscle and neutrophil
leukocytes. J Neurol Sci 1983; 62(1-3): 327-355.
2. Barth Syndrome Foundation Website: Frequently Asked
Questions. 2006. http://www.barthsyndrome.org.
3. Kelley RI, Cheatham JP, Clark BJ, Nigro MA, Powell
BR, Sherwood GW, et al. X-linked dilated cardiomyopathy
with neutropenia, growth retardation, and
3-methylglutaconic aciduria. J Pediatr. 1991; 119(5):
738-747.
4. Wortmann SB, Kluijtmans LA, Engelke UFH, Wevers
RA, Morava E. The 3-methylglutaconic acidurias:
What’s new? J Inherit Metab Dis. 2012; 35(1): 13-22.
5. Steward CG, Newbury-Ecob RA, Hastings R, Smithson
SF, Tsai-Goodman B, Quarrell OW, et al. Barth
syndrome: An X-linked cause of fetal cardiomyopathy
and stillbirth. Prenatal Diag. 2010; 30(10):
970-976.
6. Spencer CT, Bryant RM, Day J, Gonzalez IL, Colan
SD, Thompson WR, et al. Cardiac and clinical phenotype
in Barth syndrome. Pediatrics. 2006; 118(2):
e337-e346.
7. Bione S, Dadamo P, Maestrini E, Gedeon AK, Bolhuis
PA, Toniolo D. A novel X-linked gene, G4.5. is
responsible for Barth syndrome. Nat Genet. 1996;
12(4): 385-389.
8. Ades LC, Gedeon AK, Wilson MJ, Latham M, Partington
MW, Mulley JC, et al. Barth syndrome –
Clinical features and confirmation of gene localization
to distal Xq28. Am J Med Genet. 1993; 45(3):
327-334.
9. Bolhuis PA, Hensels GW, Hulsebos TJM, Baas F,
Barth PG. Mapping of the locus for X-linked cardioskeletal
myopathy with neutropenia and abnormal
mitochondria (Barth Syndrome) to Xq28. Am J Hum
Genet. 1991; 48(3): 481-485.
10. Klingenberg M. Cardiolipin and mitochondrial
carriers. Biochim Biophys Acta. 2009; 1788(10):
2048-2058.
11. Ferri L, Donati MA, Funghini S, Malvagia S, Catarzi
S, Lugli L, et al. New clinical and molecular insights
on Barth syndrome. Orphanet J Rare Dis. 2013; 8(1):
27. doi: 10.118/1750-1172-8-27.
12. Khuchua Z, Yue Z, Batts L, Strauss AW. A zebrafish
model of human Barth syndrome reveals the essential
role of tafazzin in cardiac development and function.
Circ Res. 2006; 99(2): 201-208.
13. Untergasser A, Cutcutache I, Koressaar T, Ye J, Faircloth
BC, Remm M, et al. Primer3 – new capabilities
and interfaces. Nucleic Acids Res. 2012; 40(15): e115.
14. Koressaar T, Remm M. Enhancements and modifications
of primer design program Primer3. Bioinformatics.
2007; 23(10): 1289-1291.
15. Gonzalez IL. Human tafazzin (TAZ) gene mutation
and variation database. 2012. (Science and research
section of http://www.barthsyndrome.org).
16. Chen R, Tsuji T, Ichida F, Boules KR, Yu X, Watanabe
S, et al. Mutation analysis of the G4.5 gene in
patients with isolated left ventricular noncompaction.
Mol Genet Metab. 2002; 77(4): 319-325.
17. Roberts AE, Nixon C, Steward CG, Gauvreau K,
Maisenbacher M, Fletcher M, et al. The Barth Syndrome
Registry: Distinguishing disease characteristics
and growth data from a longitudinal study. Am J
Med Genet Part A. 2012; 158A(11): 2726-2732.
18. Desmet FO, Hamroun D, Lalande M, Collod-Beroud
G, Claustres M, Beroud C. Human Splicing Finder:
An online bioinformatics tool to predict splicing signals.
Nucleic Acid Res. 2009; 37(9): e67.
19. Sakamoto O, Ohura T, Katsushima Y, Fujiwara I,
Ogawa E, Miyabayashi S, et al. A novel intronic
mutation of the TAZ (G4.5) gene in a patient with
Barth syndrome: Creation of a 5-prime splice donor
site with variant GC consensus and elongation of the
upstream exon. Hum Genet. 2001; 109(5): 559-563.
20. Clarke SL, Bowron A, Gonzalez IL, Groves SJ,
Newbury-Ecob R, Clayton N, et al. Barth syndrome.
Orphanet J Rare Dis. 2013; 8: 23. doi:
10.11861760-1172-8-23.
21. Cosson L, Toutain A, Simard G, Kulik W, Matyas G,
Guichet A, et al. Barth syndrome in a female patient.
Mol Genet Metab. 2012; 106(1): 115-120.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
